New vaccine immunoadjuvant

摘要

The present invention relates to a novel vaccine immunoassist agent and, more specifically, contains an IL-12 protein and an IL-21 protein as an active ingredient The present invention is directed to an immunomodulator of a T-lymphocyte specific immune response accelerating vaccine comprising a polynucleotide encoding the IL-12 protein and a polynucleotide encoding the IL-21 protein as an active ingredient.